Oxyresveratrol and Related Stilbenes in Retinal Diseases: Current Preclinical Evidence, Mechanistic Rationale, and Research Priorities

Oxyresveratrol is a naturally occurring stilbene known for its antioxidant, anti-inflammatory, and metabolic activities. However, its relevance to retinal disease requires careful distinction between direct ocular findings and evidence obtained with related compounds or non-ocular models. This narrative review critically examines direct retinal evidence for oxyresveratrol, comparative retinal studies of resveratrol, and non-ocular findings for mulberrosides and oxyresveratrol-containing botanical preparations. The literature search used PubMed and Google Scholar, supplemented with reference-list screening. The direct oxyresveratrol evidence discussed here includes pretreatment studies in hydrogen peroxide- or sodium iodate-exposed ARPE-19 cells and a sodium iodate-induced mouse retinal injury model. Reported improvements in cellular viability and retinal structure support further investigations of RPE oxidative injury, but methodological limitations and the predominantly preventive treatment designs preclude conclusions regarding efficacy in human age-related macular degeneration or other retinal diseases. The reported NRF2-silencing experiments did not establish that NRF2 activation was required for protection. Effects on retinal mitochondrial function, SIRT1/SIRT3 signaling, pathological angiogenesis, and adipose–retina interactions remain hypotheses requiring direct validation. Findings for resveratrol, mulberrosides, or phytochemical combinations should not be treated as interchangeable evidence of oxyresveratrol efficacy. Priorities include independent replication, post-injury treatment studies, quantitative ocular exposure assessment, and evaluation of safety and disease-specific functional outcomes. Oxyresveratrol therefore warrants further preclinical evaluation, while its translational relevance remains to be established.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-12
DOI
https://doi.org/10.3390/ijms272210135
Primary Topic
Sirtuins and Resveratrol in Medicine
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Oxyresveratrol and Related Stilbenes in Retinal Diseases: Current Preclinical Evidence, Mechanistic Rationale, and Research Priorities

Soon Sung Lim, Beom Goo Kang, Deokho Lee, Livio Vitiello
International Journal of Molecular Sciences
Sirtuins and Resveratrol in Medicine
article

Oxyresveratrol and Related Stilbenes in Retinal Diseases: Current Preclinical Evidence, Mechanistic Rationale, and Research Priorities

Soon Sung Lim, Beom Goo Kang, Deokho Lee, Livio Vitiello
article en

Abstract

Oxyresveratrol is a naturally occurring stilbene known for its antioxidant, anti-inflammatory, and metabolic activities. However, its relevance to retinal disease requires careful distinction between direct ocular findings and evidence obtained with related compounds or non-ocular models. This narrative review critically examines direct retinal evidence for oxyresveratrol, comparative retinal studies of resveratrol, and non-ocular findings for mulberrosides and oxyresveratrol-containing botanical preparations. The literature search used PubMed and Google Scholar, supplemented with reference-list screening. The direct oxyresveratrol evidence discussed here includes pretreatment studies in hydrogen peroxide- or sodium iodate-exposed ARPE-19 cells and a sodium iodate-induced mouse retinal injury model. Reported improvements in cellular viability and retinal structure support further investigations of RPE oxidative injury, but methodological limitations and the predominantly preventive treatment designs preclude conclusions regarding efficacy in human age-related macular degeneration or other retinal diseases. The reported NRF2-silencing experiments did not establish that NRF2 activation was required for protection. Effects on retinal mitochondrial function, SIRT1/SIRT3 signaling, pathological angiogenesis, and adipose–retina interactions remain hypotheses requiring direct validation. Findings for resveratrol, mulberrosides, or phytochemical combinations should not be treated as interchangeable evidence of oxyresveratrol efficacy. Priorities include independent replication, post-injury treatment studies, quantitative ocular exposure assessment, and evaluation of safety and disease-specific functional outcomes. Oxyresveratrol therefore warrants further preclinical evaluation, while its translational relevance remains to be established.

International Journal of Molecular SciencesVol. 27(22)
Hallym University (KR), Azienda Sanitaria Locale Salerno (IT)
Good health and well-being
Sirtuins and Resveratrol in Medicine
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon